PBL InterferonSource founder, Sidney Pestka, MD, to receive 'Distinguished Service Award' from 'ISICR'
PBL InterferonSource announced that its founder and chief scientific officer (CSO), Sidney Pestka, M.D., will receive the 'Distinguished Service Award' from the International Society for Interferon and Cytokine Research (ISICR) at the ISICR's annual meeting on October 3-7, 2010, in Chicago.
The ISICR bestows its 'Distinguished Service Award' on an ISICR member "who has made an extraordinary contribution to the Society. This individual will have devoted significant time and energy over a period of years to elevating the goals of the Society in furthering research on interferon, cytokines and chemokines."
"I am deeply honored to receive this award," said Dr. Petska. "Research arising from ISICR members' laboratories has led to significant breakthroughs in understanding and treating cancer, inflammatory diseases such as rheumatoid arthritis, viral diseases such as hepatitis and influenza, and autoimmune disorders such as multiple sclerosis and lupus. I am very proud to be a part of the ISICR and what it represents."
Other news from the department people
These products might interest you

Whatman™ folded filter papers by Cytiva
Whatman folded filter papers
Convenient folded formats speed up your sample preparation

Systec H-Series by Systec
Safe, reproducible and validatable sterilization of liquids, solids and waste
Autoclaves with 65-1580 liters usable space, flexibly expandable for various applications

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents

A giant, snake-like enzyme seals the fate of unwanted proteins
Allergan and Molecular Partners Enter into Exclusive Alliance - Global partnership will develop novel products for eye diseases

Catalyst to make renewable paints, coatings, and diapers discovered - Groundbreaking discovery will enable the manufacturing of biorenewable materials from trees and corn: A Startup wants to make it possible
Antisoma's phase III trial of AS1413 completes patient enrolment
